Koos de Wit

Congratulations to Prof. Ulrich Beuers, University of Amsterdam on receiving the Recognition Award at #EASLCongress 2025, which honours his outstanding contributions to hepatology and EASL, and his unwavering dedication. "Ulrich is a man of great integrity and honesty who has made an enormously significant impact, both on the hepatology community and also on so many people," said Prof. Jesús Banales during the award presentation. With his work spanning chronic cholestatic and immune-mediated liver diseases—including primary biliary cholangitis, sclerosing cholangitis, autoimmune hepatitis, and IgG4-related cholangitis—Prof. Beuers has been instrumental in advancing both our understanding and treatment of these complex conditions. @AleksanderKrag @DebbieShawcros1 @JesusMBanales @EASLedu

💊Can rifaximin-α reduce healthcare burden in #cirrhosis with recurrent #HepaticEncephalopathy? In a real-world study in 7 Dutch hospitals, it reduced: ✅HE episodes ✅Hospital & ER visits ✅Outpatient visits ✅Overall healthcare use 📖 #OpenAccess👉 bit.ly/4m3HipE

@liverunitclinic @PoseElisa @AEEHLiver Congratulations @PoseElisa well deserved!

Very proud of our colleague @PoseElisa awarded with the Rising star award of @AEEHLiver

@PoseElisa @salvatore_piano @Zac_MD @KGananandan @UschnerFrank @JonelTrebicka @JuanAbraldes @JordiGratacos8 @dewitkoos @EASLnews @AASLDtweets This group also pulled off another important paper that took about 3 years in the completion - all about novel biomarkers in cirrhosis @Gut_BMJ @LiverHope_h2020 gut.bmj.com/content/73/1/1…

Just published in @JAMA_current: the @LiverHope_h2020 trial. Simvastatin and rifaximin for decompensated cirrhosis. @PoseElisa @salvatore_piano @Zac_MD @KGananandan @UschnerFrank @JonelTrebicka @ruben_hernaez @JuanAbraldes jamanetwork.com/journals/jama/… #livertwitter

@KGananandan @FrontGastro_BMJ @PhilSmithIsBack @OTavabie @dr_aditi_kumar Congrats!

Excited to announce I've been chosen as a new trainee editor for the @FrontGastro_BMJ team! Thanks @PhilSmithIsBack @OTavabie @dr_aditi_kumar for bringing me on board! Looking forward to getting started. PS Don't forget to vote in the #FGCup!

Extremely proud te be awarded the 🇳🇱 Best Young Basal Hepatologist Award 2024 🏆 @LiverInt @EASLnews @MinnekeC @Saskia_van_Mil @UMCU_CMM @amsterdamumc @spaarnegasthuis onlinelibrary.wiley.com/doi/full/10.11…

🏆 @dewitkoos from @amsterdamumc and @spaarnegasthuis captures the 🇳🇱 Young Hepatology Award 2⃣0⃣2⃣4⃣ 💪 onlinelibrary.wiley.com/doi/10.1111/li… @LiverInt @my_ueg @easlnews @MinnekeC

#GUTImage from the paper by Juanola et al entitled "Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis" via bit.ly/3RBMfZu @Zac_MD #LiverTwitter

@bcm_gihep @liverunitclinic @Gut_BMJ @LiverHope_h2020 @AleksanderKrag @dewitkoos @mt_2589 @JonelTrebicka @PoseElisa @rajmookerjee @salvatore_piano @AsraniSumeet @JuanAbraldes and many others made this 2-year long project possible! international collaboration 👏 under #pgines support @LiverHope_h2020 kudos to these two leading it

New in JMIR: Opt-In and Opt-Out Consent Procedures for the Reuse of Routinely Recorded Health Data in Scientific #Research and Their Consequences for Consent Rate and Consent Bias: Systematic Review dlvr.it/Sk87VH

@KGananandan @LiverInt @UMCU_CMM @Saskia_van_Mil @amsterdamumc Thanks Kohi 🙏🏼

@dewitkoos @LiverInt @UMCU_CMM @Saskia_van_Mil @amsterdamumc Fantastic work, congratulations!

💥Proud to be on the cover of @LiverInt 💥 🔬Effects of Rifaximin on human small intestinal organoids: 🧫Stimulation of intracellular nitrogen detoxification 💊Apical excretion into the intestinal lumen onlinelibrary.wiley.com/toc/14783231/2… @UMCU_CMM @Saskia_van_Mil @amsterdamumc

@Saskia_van_Mil @UMCU_CMM

👋 Take a look at the TOP1 trending article from @LiverInt in social media during the past month: 🔦 #Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids 🔓 ow.ly/ymsr50MgQjJ ✍️ @dewitkoos #livertwitter

@ebtapper @LiverInt Thanks @ebtapper for your interest in our paper! Slowly we begin to understand the working mechanisms of this fascinating drug.

Rifaximin ⬇️ episodes of hepatic encephalopathy But we aren’t sure exactly why that’s why I enjoyed reading this @LiverInt paper by @dewitkoos showing that rif gets into small bowel cells and stimulates enzymes that fix nitrogen, ⬇️nh3 onlinelibrary.wiley.com/doi/10.1111/li… #livertwitter

Our paper about direct effects of Rifaximin on the human gastrointestinal epithelium is out @LiverInt Rifaximin - stimulates intracellular nitrogen detoxification - is excreted apically (into the intestinal lumen) @UMCU_CMM @Saskia_van_Mil #livertwitter onlinelibrary.wiley.com/doi/10.1111/li…

Alpe d'HuZes 🚵🏽‍♂️ - Donateurs gezocht Op donderdag 1 juni 2023 fiets ik zes keer de Alpe d'Huez op om geld in te zamelen voor onderzoek naar kanker. Wil jij mij steunen? Doneer nu via: opgevenisgeenoptie.nl/s/14360/17061/t

@MarcBonten @MinVWS @nrc Wij delen jouw mening hieromtrent @MarcBonten. In @amsterdamumc hebben we de werkgroep Ontregel het Onderzoek hiervoor opgezet: ontregelhetonderzoek.nl en zijn nog op zoek naar partijen die zich bij ons willen aansluiten vanuit andere ziekenhuizen

Nog maar n keer onder de aandacht: de AVG wordt stelselmatig misbruikt om onder t mom van privacybeleid gegevens onbereikbaar te houden. ⁦@MinVWS⁩ en anderen, doe hier iets aan! Kijk naar Denemarken. ‘RIVM en GGD laat met delen data corona’ via @nrc nrc.nl/nieuws/2022/11…

Very proud of Dr Juanola and Dr Ma for their poster presentation at #TLM22 @AASLDtweets @liverunitclinic